Latest Breaking News On - Heidi hamm - Page 1 : comparemela.com

A team of Vanderbilt researchers has created a new series of drug candidates against a hard-to-target receptor involved in the formation of blood clots. The research, spearheaded by the labs of Jens Meiler, research professor of chemistry, Craig Lindsley, Executive Director of Warren Center for Neuroscience Drug Discovery and professor of pharmacology, and Heidi Hamm, the Aileen M. Lange and Annie Mary Lyle Professor of Cardiovascular Research and professor of pharmacology, was published in ACS Pharmacology and Translational Science in March 2024.

Craig lindsleyJens meilerShannont smithAileenm langeShannon smithHeidi hammAnnie mary lyle professor of cardiovascular researchWarren centerTranslational scienceExecutive directorNeuroscience drug discoveryAnnie mary lyle professorCardiovascular researchProtease activated receptor